Observational analysis shows potential benefits of non-pulmonary vein ablation in patients with atrial fibrillation and fabry disease, indicating new treatment avenues.
Fabry disease (FD) is a rare disease that progressively causes myocardial degeneration. There are only a few low‐voltage areas, but some fractionated potentials are present in the left atrium of FD patients with atrial fibrillation (AF). Attempting non‐pulmonary vein (non‐PV) substrate ablation may be worthwhile.
No takes yet. Share an insight, caveat, or question.
Onuki et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: